Isosorbide mononitrate injection ;

Function:
Long-term treatment of coronary heart disease; prevention of angina pectoris; treatment of persistent angina pectoris after myocardial infarction; combined with digitalis and/or diuretics, treatment of chronic congestive heart failure.
Dosage:
Intravenous drip. Before use, add 0.9% sodium chloride injection or 5% glucose injection to dilute and infuse intravenously. The drug dosage can be adjusted according to the patient’s response, and the generally effective dosage is 2 to 7 mg per hour. The initial administration rate is 60ug/minute, and the general rate is 60-120ug/minute, once a day, and 10 days is a course of treatment.
Adverse reactions:
Headaches (so-called nitrate headaches) often occur in the early stages of medication, and usually disappear after a few days of continued medication. During initial administration or dose increase, there is often a decrease in blood pressure and/or orthostatic hypotension accompanied by a reflex increase in pulse rate and feelings of fatigue and dizziness. Sometimes there is nausea, vomiting, instant skin redness and heat, and skin allergic reactions. In rare cases, severe hypotension can occur accompanied by exacerbation of angina symptoms (paradoxical effect of nitrates) and/or marked paradoxical bradycardia. Collapse and syncope (sudden loss of consciousness) have occasionally been reported. In individual cases exfoliative dermatitis (inflammatory skin disease) may occur. After taking this product, transient arterial blood oxygenation deficiency may occur due to the relative redistribution of blood flow into the hypoventilated pulmonary alveolar areas. This can lead to myocardial ischemia in patients with coronary heart disease.
Drug contraindications:
Disabled if allergic to this product